A Randomised Open-label, Multicenter, Phase 2 Study Comparing the Effects on Proliferation and the Efficacy and Tolerability of Fulvestrant (FASOLDEX) 500mg with Fulvestrant 250mg when given as Neoadjuvant Treatment in Postmenopausal.......

Project Details

Short titleA Randomised Open-label, Multicenter, Phase 2 Study Comparing the Effects on Proliferation and the Efficacy and Tolerability of Fulvestrant (FASOLDEX) 500mg with Fulvestrant 250mg when given as Neoadjuvant Treatment in Postmenopausal.......
StatusFinished
Effective start/end date1/07/06 → 30/06/07

Funding

  • Queen Elizabeth Hospital